IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TARS), today announced that management will participate in ...

Though Demodex mites are often seen as unwelcome guests, they play an essential role in the skin’s ecosystem. By maintaining ...

is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the ...

Ocular Rosacea – Pursuing The Next Potentially ... and more than half of all cases are caused by an infestation of Demodex mites. This inflammatory condition affects the eyes and surrounding ...

Moreover, Tarsus is extending its reach into ocular rosacea, a condition with no FDA ... is a novel drug that targets the Demodex mite nervous system to kill the mites. Read More on TARS: Tarsus ...

If you've ever suffered from common skin conditions like rosacea, eczema or psoriasis, you know how uncomfortable the itching, irritation and redness can be. Fortunately, you don't have to suffer in ...

Blepharitis is a common chronic condition that affects the eyelids, causing inflammation along the eyelid margins.

Conclusions IVCM could be a safe, effective and reliable tool to quantify alterations of the cornea, MG and cheek glands in patients with rosacea combined with quantification of Demodex infections. As ...

Groundbreaking data from the Ersa and Rhea clinical trials for the treatment of Demodex blepharitis (DB) in patients with Meibomian Gland Disease (MGD) further underscore the utility of XDEMVY broadly ...